Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates: from bench to bedside.

R Graham G Russell1

  • 1The Botnar Research Centre, Nuffield Department of Orthopaedic Surgery, University of Oxford, Headington, Oxford, OX3 7LD, UK. graham.russell@ndos.ox.ac.uk

Annals of the New York Academy of Sciences
|July 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bisphosphonates Trigger Anti-Ageing Effects Across Multiple Cell Types and Protect Against Senescence.

bioRxiv : the preprint server for biology·2025
Same author

Rapid assessment of the osteogenic capacity of hydroxyapatite/aragonite using a murine tibial periosteal ossification model.

Bioactive materials·2024
Same author

Introduction to the Bisphosphonate Special Issue.

Bone·2023
Same author

<i>In vitro</i> and <i>in vivo</i> effects of zoledronate on senescence and senescence-associated secretory phenotype markers.

bioRxiv : the preprint server for biology·2023
Same author

Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen <i>Staphylococcus aureus</i> Treated with Novel Bisphosphonate-Fluoroquinolone Antimicrobial Conjugates.

International journal of molecular sciences·2023
Same author

Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.

Bone·2021
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Bisphosphonates are key drugs for bone diseases, inhibiting osteoclast activity. Nitrogen-containing bisphosphonates target the mevalonate pathway, crucial for bone resorption treatment.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Bone Biology

Background:

  • Bisphosphonates (BPs) are vital drugs for treating bone resorption diseases like osteoporosis.
  • They are stable analogues of inorganic pyrophosphate, resisting enzymatic breakdown.
  • BPs are selectively adsorbed to bone mineral, interfering with osteoclast function.

Purpose of the Study:

  • To review the discovery and development of bisphosphonates.
  • To elucidate the molecular mechanisms of action for different bisphosphonate classes.
  • To highlight the therapeutic applications and ongoing research in bisphosphonate therapy.

Main Methods:

  • Review of established bisphosphonate drugs and their clinical applications.
  • Analysis of the chemical structure and stability of bisphosphonates.

Related Experiment Videos

  • Biochemical investigation into the intracellular targets and pathways affected by bisphosphonates.

    • Main Results:

    • Bisphosphonates inhibit bone resorption by targeting osteoclasts.
    • Non-nitrogen-containing BPs form toxic ATP analogues, inhibiting ATP-dependent enzymes.
    • Nitrogen-containing BPs inhibit farnesyl pyrophosphate synthase (FPPS) in the mevalonate pathway, disrupting protein prenylation and inducing osteoclast apoptosis.

    Conclusions:

    • Bisphosphonates are established treatments for various bone diseases.
    • Understanding their mechanism, particularly the inhibition of FPPS, is crucial.
    • Ongoing research continues to reveal the full therapeutic potential of bisphosphonates.